JaneLoweMeiselMD

PubMed

• PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Horm...
  Erica L Mayer, Yue Ren, Nikhil Wagle, Reshma Mahtani, Cynthia Ma, Angela DeMichele, Massimo Cristofanilli, Jane Meisel, Kathy D Miller, Yara Abdou, Elizabeth C Riley, ...> ;Journal of Clinical Oncology. 2024 Mar 21
• High tumor infiltrating lymphocytes are significantly associated with pathological complete response in triple negative breast cancer treated with neoadjuvant KEYNOTE-...
  Wood, S., Gao, Y., Lee, J., Chen, J., Wang, Q., Meisel, J., Li, X.> ;Breast Cancer Research and Treatment. 2024 Jan 30
• 1 citations
  Correlation of HER2 Protein Level With mRNA Level Quantified by RNAscope in Breast Cancer.
  Lee, J., Gao, Y., Zhang, J., Bates, K., Lawson, D., Li, X., Rimm, D., Zhang, H., Smith, G., Meisel, J., Chang, J., Huo, L.> ;Modern Pathology. 2024 Feb 1
• 1 citations
  Impact of BMI in Patients With Early Hormone Receptor-Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial.
  Georg Pfeiler, Dominik Hlauschek, Erica L Mayer, Christine Deutschmann, Stephanie Kacerovsky-Strobl, Miguel Martin, Jane Lowe Meisel, Nicholas Zdenkowski, Sibylle Loib...> ;Journal of Clinical Oncology. 2023 Nov 20
• 1 citations
  Improving palbociclib adherence among women with metastatic breast cancer using a CONnected CUstomized Treatment Platform: A pilot study.
  Gelareh Sadigh, Jane L Meisel, Kristina Byers, Andrew Robles, Leslie Serrano, Olivia S Jung, Debrua Coleman, Katherine A Yeager, Ilana Graetz> ;Journal of Oncology Pharmacy Practice. 2023 Dec 1
• 2 citations
  Predicting outcomes in female germ cell tumors using a modified International Germ Cell Cancer Collaborative Group classification system to guide management.
  Ying L Liu, Beryl L Manning-Geist, Andrea Knezevic, Luxue Deng, Maria Bromberg, Samuel A Funt, Jane L Meisel, Oliver Zivanovic, Kara Long Roche, Yukio Sonoda, Ginger J...> ;Gynecologic Oncology. 2023 Mar 1
• 1 citations
  A Discordant Pattern of Uptake on 68 Ga-PSMA PET/CT Versus 18 F-Fluciclovine PET/CT in Radiation-Induced Hepatitis : Implications for Early Postradiotherapy Imaging-Ba...
  Omotayo A Adediran, Ismaheel O Lawal, Saima Muzahir, Manali A Bhave, Sarah Friend, Bridget Fielder, Jane Meisel, Mylin A Torres, Toncred M Styblo, Cathy Graham, Anna H...> ;Clinical Nuclear Medicine. 2023 Apr 1
• 1 citations
  Percutaneous CT-Guided Cryoneurolysis of the Intercostobrachial Nerve for Management of Postmastectomy Pain Syndrome.
  Nariman Nezami, Alex Behi, Sivasai Manyapu, Jane L Meisel, Neil Resnick, David Corn, J David Prologo> ;Journal of Vascular and Interventional Radiology. 2023 May 1
• When the personal becomes political: The impact of the Dobbs decision on women with cancer.
  Jane Lowe Meisel, Amy Harrington, Natalie Whaley, Wendy Vitek, Ruth M O'Regan> ;Cancer. 2023 Jan 15
• 1 citations
  Study Protocol: Efficacy and Safety of Radioembolization (REM) as an Early Modality (EM) Therapy for Metastatic Breast Cancer (BR) to the Liver with Y90 (REMEMBR Y90).
  Richard Wu, Keerthi Gogineni, Jane Meisel, Stephen Szabo, Meenakshi Thirunavu, Sarah Friend, Zachary Bercu, Ila Sethi, Neela Natarajan, Jeffrey Switchenko, Jason Levy,...> ;Cardiovascular and Interventional Radiology. 2022 Nov 1
• 1 citations
  Evaluating the Effectiveness of a Telehealth Cancer Genetics Program: A BRCA Pilot Study.
  Esther Rose, Melanie Walker Hardy, Rachael Gates, Christine Stanislaw, Jane Meisel, Karen Arnovitz Grinzaid> ;Public Health Genomics. 2022 Aug 9
• 1 citations
  Utility of Oncotype DX score in clinical management for T1 estrogen receptor positive, HER2 negative, and lymph node negative breast cancer.
  Thi Truc Anh Nguyen, Lauren M Postlewait, Chao Zhang, Jane L Meisel, Ruth O'Regan, Sunil Badve, Kevin Kalinsky, Xiaoxian Li> ;Breast Cancer Research and Treatment. 2022 Apr 1
• 26 citations
  Correlates of financial toxicity in adult cancer patients and their informal caregivers
  Gelareh Sadigh, Jeffrey M. Switchenko, Kathryn E. Weaver, Jane L. Meisel, Mehmet Asim Bilen, David H. Lawson, David Cella, Bassel F. El-Rayes, Ruth C. Carlos> ;Supportive Care in Cancer. 2022 Jan 1
• 2 citations
  Are we closer to being able to select patients with node-positive hormone receptor-positive breast cancer who can safely omit chemotherapy?
  Caitlin Taylor, Jane Meisel, Kevin Kalinsky> ;Therapeutic Advances in Medical Oncology. 2022 Jan 1
• 10 citations
  Molecular Classification of Triple Negative Breast Cancer and the Emergence of Targeted Therapies.
  Elizabeth Sakach, Ruth M. O’Regan, Jane L. Meisel, Xiaoxian Li> ;Clinical Breast Cancer. 2021 Sep 17
• 3 citations
  Folate Receptor Alpha Is Preferentially Expressed in the Carcinoma Component of Endometrial Carcinosarcomas: A Potential Target for Adjuvant Therapy.
  Krisztina Z. Hanley, Ira R. Horowitz, Alan N. Gordon, Jane L. Meisel, Namita Khanna> ;International Journal of Gynecological Pathology. 2021 Sep 1
• We have to talk about it: Bringing fertility into the conversation for young women with breast cancer
  Caitlin E. Taylor, Jane L. Meisel> ;Cancer. 2021 Aug 15
• 3 citations
  Weighing the influence of race and obesity on outcomes in patients with early-stage breast cancer
  Caitlin E. Taylor, Jane L. Meisel> ;Cancer. 2021 Mar 15
• 9 citations
  HER2 immunohistochemistry staining positivity is strongly predictive of tumor response to neoadjuvant chemotherapy in HER2 positive breast cancer
  Jing Zhao, Uma Krishnamurti, Chao Zhang, Jane L. Meisel, Zhimin Wei, Aili Suo, Ritu Aneja, Zaibo Li, Xiaoxian Li> ;Pathology, Research and Practice. 2020 Nov 1
• 9 citations
  The Impact of Genetic Counseling Educational Tools on Patients’ Knowledge of Molecular Testing Terminology
  Brianna A. McDaniels, Rachel S. Hianik, Cecelia Bellcross, Walid L. Shaib, Jeffrey M. Switchenko, Margie D. Dixon, Jane L. Meisel, Keerthi Gogineni, Rebecca D. Pentz> ;Journal of Cancer Education. 2020 Oct 1
• 2 citations
  Optimizing the duration of trastuzumab: A fresh perspective
  Melissa A. Taylor, Kristina F Byers, Jane L. Meisel> ;Oncology. 2020 Aug 10
• 10 citations
  Evaluation of PD-L1, tumor-infiltrating lymphocytes, and CD8+ and FOXP3+ immune cells in HER2-positive breast cancer treated with neoadjuvant therapies.
  Jing Zhao, Jane L. Meisel, Yi Guo, Rita Nahta, Kung Lin Hsieh, Limin Peng, Zhimin Wei, Ruth O'Regan, Xiaoxian Li> ;Breast Cancer Research and Treatment. 2020 Jul 26
• Pilot Feasibility Study of a Video Intervention to Educate Patients with Breast Cancer About Clinical Trials.
  Katherine A. Yeager, Jinbing Bai, Keerthi Gogineni, Jane L. Meisel, Jaime Kweon, Deborah Watkins Bruner, Drenna Waldrop-Valverde> ;Journal of Cancer Education. 2020 Jul 11
• 4 citations
  The Influence of Histologic Grade on Outcomes of Elderly Women With Early Stage Breast Cancer Treated With Breast Conserving Surgery With or Without Radiotherapy
  Chase E. Escott, D. Zaenger, Jeffrey M. Switchencko, J.Y. Lin, Mustafa Abugideiri, Cletus A. Arciero, Neil T. Pfister, Karen M. Xu, Jane L. Meisel, Preeti Subhedar, My...> ;Clinical Breast Cancer. 2020 May 13
• 22 citations
  Clinicopathologic Factors Associated With Response to Neoadjuvant Anti-HER2-Directed Chemotherapy in HER2-Positive Breast Cancer.
  Jane L. Meisel, Jing Zhao, Aili Suo, Chao Zhang, Zhimin Wei, Caitlin E. Taylor, Ritu Aneja, Uma Krishnamurti, Zaibo Li, Rita Nahta, Ruth O'Regan, Xiaoxian Li> ;Clinical Breast Cancer. 2020 Feb 1
• Join now to see all

Lectures

• Creating Connections and Building Community: Social Media and Physician Quality of Life 
  ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019
• The Continuing Evolution of Targeted Therapy in Breast Cancer 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/1/2018